The Development of Upper Extremity Rehabilitation Program Using Virtual Reality for the Stroke Patients

Mobile Game-based Virtual Reality Rehabilitation Program for Upper Limb Dysfunction After Ischemic Stroke

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02013999

Enrollment

Registered

2013-12-17

Start date

2013-10-31

Completion date

2014-11-24

Last updated

2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity Dysfunction After the Stroke

Brief summary

Using the upper extremity rehabilitation program developed by virtual reality would help the recovery upper extremity function in patients with stroke.

Detailed description

This randomized, double-blind, controlled trial included 24 patients with ischemic stroke. The intervention group received 30 min of conventional occupational therapy (OT) and 30 min of the mobile upper extremity rehabilitation program using a smartphone and a tablet PC (MoU-Rehab). The controls (n = 12) received conventional OT alone for 1 h per day. Rehabilitation consisted of 10 sessions of therapy, 5 days per week, for 2 weeks. The outcome measures (Fugl-Meyer Assessment of the upper extremity \[FMA-UE\], Brunnstr¨om stage \[B-stage\] for the arm and the hand, manual muscle testing \[MMT\], modified Barthel index \[MBI\], EuroQol-5 Dimension \[EQ-5D\], and Beck Depression Inventory \[BDI\]) were assessed at the beginning and end of treatment, and at 1 month. User satisfaction was evaluated by a qestionnaire.

Interventions

OTHERVirtual reality program for upper extremity rehabilitation

OTHERstandard occupational therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* ischemic or hemorrhagic stroke confirmed by brain imaging study * upper extremity dysfunction * possible to use a simple device

Exclusion criteria

* delirium, confusion or other evidence related to the consciousness * uncontrolled medical or surgical disease * unable to command to the order due to severe cognitive impairment * visual impairment * unable to sit

Design outcomes

Primary

Measure	Time frame	Description
Fugl-Meyer upper extremity scale	baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks	for motor evaluation

Secondary

Measure	Time frame	Description
Modified Barthel Index	baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks	for ADL independence
Medical Research Council (MRC) Scale for Muscle Strength	baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks	for motor evaluation
brunnström stage	baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks	for motor evaluation
Virtual reality kinematic data	everytime when the patient uses program (automatically all recorded)	Automatically recorded
questionnaire	at the end of the treatment for 2 weeks	for user satisfaction
Euroqol(EQ)-5D	baseline(just before beginning the treatment), at the end of the treatment for 2 weeks, 1 month later of the end of the treatment for 2 weeks	EQ-5D

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026